Abstract:Introduction The study aims to explore the utility of BDNF Val66Met polymorphism as a potential biomarker in Indian bipolar disorder patients and its correlation with clinical characteristics. Objectives Genotyping Val66Met in BDNF gene Exploring its association with bipolar disorder (BD). Methods 150 consenting BD patients and matched controls were recruited using a case-control study design. BD severity was assessed using Young's mania rating scale and the Clinical Global Impression - Severity (CGI-S) scale. BDNF Val66Met polymorphism was identified through real-time PCR after DNA extraction. Data was tested for normal distribution. Genotype frequencies between two groups were compared and the Hardy-Weinberg equilibrium assumptions were tested using Chi-Square tests. Clinical-genotypic associations were explored using the Kruskal-Wallis test and confirmed using hierarchical regression. Results Our sample had more males (60%) than females (40%) with mean age of 35.05 years. Most patients had established bipolar disorder and were severely ill (CGI: 38.75, YMRS). Val66Met SNP genotype frequency differed significantly between cases and controls. Val66Val genotype and Val allele were higher in cases. Results consistent with Hardy-Weinberg equilibrium. Table 1. Genotype frequencies of BDNF (rs6265) in cases and controls GENOTYPE CC CT TT CASES 94(62.6%) 47(31.3%) 9(6%) CONTROL 71(47.3%) 69(46%) 10(6.6%) CHI-SQUARE- 7.431 DF(Degree of freedom) - 2 p-value- 0.024 Table 2. Dominant genotype frequencies in cases and controls DOMINANT GENOTYPE CC CT+TT CASES 94(62.6%) 56(37.3%) CONTROLS 71(47.3%) 79(52.6) CHI-SQUARE-7.125 DF(Degree of freedom)-1 p-value-0.007 Table 3. Allelic frequencies of BDNF (rs6265) in BD cases and healthy controls ALLELIC VARIATION C T CASES 235(78.3%) 65(21.6%) CONTROLS 211(70.3%) 89(29.6%) CHI-SQUARE-5.032 DF(Degree of freedom)-1 p-value- 0.024 Conclusions Our study found that Val66Val genotype and Val allele were higher in cases and could be a potential biomarker for bipolar disorder (BD), which is consistent with previous research conducted on the European population. However, further investigations are required to gain a more comprehensive understanding of its impact on BD, including its association with serum BDNF levels, treatment outcomes, and a more diverse study population. Disclosure of Interest None Declared

Functional Val66Met polymorphism of Brain-derived neurotrophic factor in type 2 diabetes with depression in Han Chinese subjects

Association Of Brain-Derived Neurotrophic Factor Genetic Val66met Polymorphism With Severity Of Depression, Efficacy Of Fluoxetine And Its Side Effects In Chinese Major Depressive Patients

Association of BDNF Val66Met polymorphism with both baseline HRQOL scores and improvement in HRQOL scores in Chinese major depressive patients treated with fluoxetine.

Association of MTHFR C677T Polymorphism and Type 2 Diabetes Mellitus (T2DM) Susceptibility

Positive Association Between the Brain-Derived Neurotrophic Factor (bdnf) Gene and Bipolar Disorder in the Han Chinese Population

The brain-derived neurotrophic-factor (BDNF) val66met polymorphism is associated with geriatric depression: a meta-analysis.

Association Between Dopamine Beta-Hydroxylase 19-Bp Insertion/Deletion Polymorphism and Major Depressive Disorder

Association Between Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Methamphetamine Use Disorder: A Meta-Analysis

Elevated Peripheral Brain-Derived Neurotrophic Factor Level Associated With Decreasing Insulin Secretion May Forecast Memory Dysfunction in Patients With Long-Term Type 2 Diabetes

Interaction Between Job Stress and the BDNF Val66Met Polymorphism Affects Depressive Symptoms in Chinese Healthcare Workers.

Associations of Common Variants in Methionine Metabolism Pathway Genes with Plasma Homocysteine and the Risk of Type 2 Diabetes in Han Chinese

Effects of Polymorphisms of Serotonin Transporter Promoter (5-HTTLPR) and Brain Derived Neurotrophic Factor Gene (G196A Rs6265) on the Risk of Major Depressive Disorder in the Chinese Han Population.

Sex-specific Association of Brain-Derived Neurotrophic Factor (BDNF) Val66Met Polymorphism and Plasma BDNF with Attention-Deficit/hyperactivity Disorder in a Drug-Naïve Han Chinese Sample

Association of the Val66Met polymorphism of the BDNF gene and the deletional mutation of CYP2D6 gene with the prevalence and severity of depressive disorder in an Eastern Indian population

The BDNF Val66Met polymorphism serves as a potential marker of body weight in patients with psychiatric disorders

Relationship between a BDNF gene polymorphism and the brain volume in treatment-naive patients with major depressive disorder: A VBM analysis of brain MRI

GoGoGo : Improving Deep Neural Network Based Go Playing AI with Residual Networks

Association of Plasma DPP4 Activity and Brain-Derived Neurotrophic Factor with Moderate to Severe Depressive Symptoms in Patients with Type 2 Diabetes: Results from a Cross-Sectional Study.

RAGE Gly82Ser Polymorphism in Patients with Type 2 Diabetes with Comorbid Depression.

Comparison of Val66met Polymorphism of BDNF gene in patients of bipolar disorder and healthy controls.

Variant brain-derived neurotrophic factor Val66Met polymorphism alters vulnerability to stress and response to antidepressants